The efficacy of gepotidacin was non-inferior to nitrofurantoin in both trials ... The Lancet (2024). DOI: 10.1016/S0140-6736(23)02196-7 Ased S M Ali et al, Gepotidacin, a new first-in-class ...

However, for some areas in England, nitrofurantoin resistance in urinary Escherichia coli (the most common cause of UTI) has recently risen to over 10%, bringing it close to levels where it can no ...